TCMD NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Tactile Systems Technology Inc · Healthcare · Medical Devices

Latest close 28.17 USD
2.5% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is 4.0% above the Trend Line and sits at 65.9% of its 52-week range. The latest completed week returned 2.5%, after a -10.1% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is neither clearly cheap nor expensive. Options positioning is mixed with 29/100 conviction, while the latest news-sentiment score is 55/100. Near-term considerations: volume confirmation is below normal; earnings are due in 2d.

Setup score 41 out of 100
Latest Close 28.17 USD 31 Jul 2026
1W Return 2.5% latest completed week
4W Return -10.1% short-term follow-through
12W Return 9.8% quarterly tape
Trend Breadth 55.8% 29 of 52 weeks active
Volume Ratio 0.8x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • 7 reversal markers appear in the recent smart-money tape.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 4.0% above the Trend Line and sits at 65.9% of its 52-week range. The latest completed week returned 2.5%, after a -10.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.5912-week average 0.38

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership10/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.59Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers77 reversal markers

No recent accumulation markers. 7 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -10.1% over four weeks, 9.8% over 12 weeks, and 191.9% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W2.5%
4W-10.1%
12W9.8%
26W-2.4%
52W191.9%
Active trend streak0 weeks
Active weeks in one year29
Trend breadth55.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.38Latest activity-pressure read.
Pressure change63.3%Four-week change in activity pressure.
Leadership9.30Latest relative-leadership reading.
RS change-60.0%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength78/100Blend of value, momentum, and quality. Underlying universe rank 23; rank 1 is best.
Value31/100Relative valuation strength. Underlying universe rank 70; rank 1 is best.
Quality93/100Profitability and accounting quality. Underlying universe rank 8; rank 1 is best.
Momentum98/100Medium-term price momentum. Underlying universe rank 3; rank 1 is best.
Growth83/100Revenue and earnings growth. Underlying universe rank 18; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework63/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
30.5x
Price divided by trailing earnings.
Price / sales
1.8x
Market value relative to trailing revenue.
EV / EBITDA
13.5x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
8.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
75.7%
Gross profit retained from each unit of revenue.
Operating margin
10.2%
Operating profit retained from revenue.
Free-cash-flow margin
13.1%
Free cash flow generated from revenue.
Return on invested capital
13.0%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
17.2%
Latest one-year revenue growth.
EPS growth
25.3%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
5.8%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
2.8%
Net share repurchases relative to market value.
Shareholder yield
2.8%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-1.4x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningMixed

TCMD shows mixed options pressure with a 29/100 conviction score, put-call volume ratio of n/a, expected move of 21.2%, and Sharemaestro trend signal inactive.

Conviction29/100
Expected move21.2%
Put/call volume
Pressure9
Speculation0
Volatility96
Trend agreement60
Open options detail
Insider activity8 / 1

8 acquisitions and 1 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment55/100

Weighted news tone is neutral across 59 relevant articles.

19 positive · 37 neutral · 3 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings2dNext report is scheduled for 03 Aug 2026; event risk rises as the date approaches.
Options expected move21.2%Nearest-chain priced movement where available.
52-week drawdown-25.4%Distance below the 52-week high.
13-week volatility6.9%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+13.7%Week of 26 Jun.
Worst week-11.3%Week of 15 May.
Latest week+2.5%Week of 31 Jul.

Shape of recent returns

Strong gains5
Modest gains7
Flat weeks0
Modest losses6
Sharp losses8
Recent vol6.9%13-week weekly-return volatility.
Base vol11.0%52-week weekly-return volatility.
Up/down split30/22Count of positive and negative weeks in the 52-week window.
Average skew7.6% / -4.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202628.17 USD2.5%27.10 USD17.25 USD0.389.301.1MOff
24 Jul 202627.48 USD-4.4%27.07 USD17.20 USD0.498.52960.7KOff
17 Jul 202628.74 USD-3.7%27.14 USD17.17 USD0.7112.941.1MOff
10 Jul 202629.83 USD-4.8%27.15 USD17.13 USD0.5313.801.0MOff
3 Jul 202631.35 USD3.5%27.08 USD17.10 USD0.2323.281.0MOff
26 Jun 202630.28 USD13.7%26.97 USD17.05 USD-0.1421.792.0MOff
19 Jun 202626.62 USD1.2%26.82 USD17.02 USD-0.673.60832.0KOff
12 Jun 202626.31 USD3.6%26.78 USD17.00 USD-0.846.13865.5KOff
5 Jun 202625.40 USD3.2%26.70 USD16.98 USD-1.035.881.3MOff
29 May 202624.61 USD-1.2%26.68 USD16.97 USD-0.96-1.091.1MOff
22 May 202624.90 USD9.5%26.36 USD16.97 USD-1.053.821.3MOff
15 May 202622.74 USD-11.3%26.03 USD16.93 USD-1.16-3.141.9MOff
8 May 202625.65 USD12.1%25.76 USD16.92 USD-1.139.683.2MOff
1 May 202622.89 USD-8.7%25.38 USD16.90 USD-1.354.261.8MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.